Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Cancer Discov. 2012 Jun;2(6):489-91. doi: 10.1158/2159-8290.CD-12-0177.
Jahid and colleagues have shown that miR-23a promotes the transition from indolent to invasive colorectal cancer through inhibition of the MTSS1 tumor suppressor. This study reveals a novel role of miR-23a in the acceleration of colorectal cancer progression.
贾希德及其同事表明,miR-23a 通过抑制 MTSS1 肿瘤抑制因子促进从惰性到侵袭性结直肠癌的转变。这项研究揭示了 miR-23a 在加速结直肠癌进展中的新作用。